DNA Copy Number Aberrations in Breast Cancer by Array Comparative Genomic Hybridization

Yang, 2005, Statistics on cancer in China: cancer registration in 2002, Eur. J. Cancer Prev., 14, 329, 10.1097/00008469-200508000-00004 Struski, 2002, Compilation of published comparative genomic hybridization studies, Cancer Genet. Cytogenet., 135, 63, 10.1016/S0165-4608(01)00624-0 Pinkel, 2005, Array comparative genomics hybridization and its application in cancer, Nat. Genet., 37, S11, 10.1038/ng1569 Dent, 1996, Axillary lymphadenectomy for breast cancer. Paradigm shifts and pragmatic surgeons, Arch. Surg., 131, 1125, 10.1001/archsurg.1996.01430230007001 Daidone, 1990, Proliferative activity of primary breast cancer and of synchronous lymph node metastases evaluated by [3H]-thymidine labelling index, Cell Tissue Kinet., 23, 401 Feichter, 1989, DNA index and cell cycle analysis of primary breast cancer and synchronous axillary lymph node metastases, Breast Cancer Res. Treat., 13, 17, 10.1007/BF01806546 Goodson, 1993, Tumor labeling indices of primary breast cancers and their regional lymph node metastases, Cancer, 71, 3914, 10.1002/1097-0142(19930615)71:12<3914::AID-CNCR2820711219>3.0.CO;2-N Lahdesmaki, 2004, Distinguishing key biological pathways between primary breast cancers and their lymph node metastases by gene function-based clustering analysis, Int. J. Oncol., 24, 1589 Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093 Weigelt, 2005, No common denominator for breast cancer lymph node metastasis, Br. J. Cancer, 93, 924, 10.1038/sj.bjc.6602794 Li, 2008, Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis, Proteomics, 8, 5038, 10.1002/pmic.200800303 Hermsen, 1998, Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors, J. Pathol., 186, 356, 10.1002/(SICI)1096-9896(199812)186:4<356::AID-PATH196>3.0.CO;2-Z Walker, 1997, Molecular pathology of breast cancer and its application to clinical management, Cancer Metastasis Rev., 16, 5, 10.1023/A:1005740222307 Gregory, 2000, Prognostic relevance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy, Breast Cancer Res. Treat., 59, 171, 10.1023/A:1006394317282 Simpson, 2005, Molecular evolution of breast cancer, J. Pathol., 205, 248, 10.1002/path.1691 Simon, 2004 Albertson, 2003, Profiling breast cancer by array CGH, Breast Cancer Res. Treat., 78, 289, 10.1023/A:1023025506386 Loo, 2004, Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes, Cancer Res., 64, 8541, 10.1158/0008-5472.CAN-04-1992 Beckmann, 1997, Multistep carcinogenesis of breast cancer and tumour heterogeneity, J. Mol. Med., 75, 429, 10.1007/s001090050128 Goldhirsch, 1998, Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer, J. Natl. Cancer Inst., 90, 1601, 10.1093/jnci/90.21.1601 van’t Veer, 2002, Gene expression profiling predicts clinical outcome of breast cancer, Nature, 415, 530, 10.1038/415530a van de Vijver, 2002, A gene-expression signature as a predictor of survival in breast cancer, N. Engl. J. Med., 347, 1999, 10.1056/NEJMoa021967 Nemoto, 1983, Breast cancer in the medial half. Results of 1978 National Survey of the American College of Surgeons, Cancer, 51, 1333, 10.1002/1097-0142(19830415)51:8<1333::AID-CNCR2820510802>3.0.CO;2-T Paris, 2006, Genomic profiling of hormonenaive lymph node metastases in patients with prostate cancer, Neoplasia, 8, 1083, 10.1593/neo.06421 D’Eredita, 2001, Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution, Eur. J. Cancer, 37, 591, 10.1016/S0959-8049(00)00435-4 Quiet, 1995, Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up, J. Clin. Oncol., 13, 1144, 10.1200/JCO.1995.13.5.1144 Revillion, 1998, ERBB2 oncogene in human breast cancer and its clinical significance, Eur. J. Cancer, 34, 791, 10.1016/S0959-8049(97)10157-5 Wilson, 2002, Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues, Am. J. Pathol., 161, 1171, 10.1016/S0002-9440(10)64394-5 Richard, 2000, Patterns of chromosomal imbalances in invasive breast cancer, Int. J. Cancer, 89, 305, 10.1002/1097-0215(20000520)89:3<305::AID-IJC15>3.0.CO;2-8 Clark, 2000, Prognostic and predictive factors, 489 Chin, 2007, Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers, Oncogene, 26, 1959, 10.1038/sj.onc.1209985 Hayes, 2005, Prognostic and predictive factors revisited, Breast, 14, 493, 10.1016/j.breast.2005.08.023 Ma, 2006, Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies, Breast Cancer Res., 8, R43, 10.1186/bcr1525 Li, 2003, Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years, Arch. Intern. Med., 163, 2149, 10.1001/archinte.163.18.2149 Loveday, 2000, Genetic changes in breast cancer detected by comparative genomic hybridisation, Int. J. Cancer, 86, 494, 10.1002/(SICI)1097-0215(20000515)86:4<494::AID-IJC8>3.0.CO;2-O Nishizaki, 1997, Genetic alterations in lobular breast cancer by comparative genomic hybridization, Int. J. Cancer, 74, 513, 10.1002/(SICI)1097-0215(19971021)74:5<513::AID-IJC6>3.0.CO;2-6 Gunther, 2001, Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization, J. Pathol., 193, 40, 10.1002/1096-9896(2000)9999:9999<::AID-PATH745>3.0.CO;2-N Stange, 2006, High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer, Clin. Cancer Res., 12, 345, 10.1158/1078-0432.CCR-05-1633 Acs, 2001, Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications, Am. J. Clin. Pathol., 115, 85, 10.1309/FDHX-L92R-BATQ-2GE0 Korkola, 2003, Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis, Cancer Res., 63, 7167 Zhao, 2004, Different gene expression patterns in invasive lobular and ductal carcinomas of the breast, Mol. Biol. Cell, 15, 2523, 10.1091/mbc.e03-11-0786 Elston, 1991, Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathology, 19, 403, 10.1111/j.1365-2559.1991.tb00229.x Joensuu, 2003, Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study, Clin. Cancer Res., 9, 923 Celis, 2003, Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research, Mol. Cell. Proteomics, 2, 369, 10.1074/mcp.R300007-MCP200 Zhang, 2005, High-resolution mapping of genotype-phenotype relationships in cri du chat syndrome using array comparative genomic hybridization, Am. J. Hum. Genet., 76, 312, 10.1086/427762 Olshen, 2004, Circular binary segmentation for the analysis of array-based DNA copy number data, Biostatistics, 5, 557, 10.1093/biostatistics/kxh008 Willenbrock, 2005, A comparison study: applying segmentation to array CGH data for downstream analyses, Bioinformatics, 21, 4084, 10.1093/bioinformatics/bti677 de Hoon, 2004, Open source clustering software, Bioinformatics, 20, 1453, 10.1093/bioinformatics/bth078 Golub, 1999, Molecular classification of cancer: class discovery and class prediction by gene expression monitoring, Science, 286, 531, 10.1126/science.286.5439.531 Li, 2007, Snap: an integrated SNP annotation platform, Nucleic Acids Res., 35, D707, 10.1093/nar/gkl969